# Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy

> **NCT02432365** · PHASE2 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** cisplatin
- **PROCEDURE:** Radical hysterectomy and bilateral pelvic lymphadenectomy

## Key facts

- **NCT ID:** NCT02432365
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432365, "Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02432365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*